- Report
- December 2024
- 150 Pages
Global
From €5228EUR$5,950USD£4,510GBP
- Report
- May 2025
- 196 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- May 2025
- 191 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- May 2025
- 184 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- May 2025
- 182 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- May 2025
- 196 Pages
Global
From €3115EUR$3,545USD£2,687GBP
€3461EUR$3,939USD£2,986GBP
- Report
- April 2025
- 200 Pages
Global
From €3945EUR$4,490USD£3,403GBP
- Report
- December 2024
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP
- Report
- July 2025
- 361 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 177 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 469 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 477 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- July 2025
- 189 Pages
Global
From €5140EUR$5,850USD£4,434GBP
- Report
- September 2024
- 145 Pages
Global
From €2635EUR$2,999USD£2,273GBP
- Report
- November 2024
- 188 Pages
Global
From €3361EUR$3,825USD£2,899GBP
€3954EUR$4,500USD£3,411GBP
- Clinical Trials
- April 2025
- 90 Pages
Global
From €2197EUR$2,500USD£1,895GBP
- Report
- March 2025
- 210 Pages
Global
From €4389EUR$4,995USD£3,786GBP
- Report
- February 2025
- 130 Pages
Global
From €4262EUR$4,850USD£3,676GBP
- Report
- November 2024
- 90 Pages
North America
From €3031EUR$3,450USD£2,615GBP
- Report
- November 2023
- 171 Pages
Global
From €4086EUR$4,650USD£3,524GBP

The Abuse Deterrent market within the context of Analgesics is a growing sector of the pharmaceutical industry. Abuse Deterrent formulations are designed to reduce the potential for misuse and abuse of prescription medications. These formulations are designed to make the drug less attractive to abusers, such as by making it harder to crush, snort, or inject. Abuse Deterrent formulations are also designed to reduce the potential for accidental overdose.
The Abuse Deterrent market is driven by the need to reduce the misuse and abuse of prescription medications, as well as the need to reduce the potential for accidental overdose. This market is expected to continue to grow as more pharmaceutical companies develop Abuse Deterrent formulations.
Some companies in the Abuse Deterrent market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Johnson & Johnson. Show Less Read more